Hetzel D
East Adelaide Medical Centre, South Australia.
Aust Fam Physician. 1998 Jun;27(6):487-91.
The place of acid pump inhibitors at the top of the efficacy table in the league of reflux therapies, and their eager patient acceptance, has aroused debate on their role.
To understand the role of gastric acid and its inhibition in the pathogenesis and treatment of gastroesophageal reflux disease.
Gastroesophageal reflux disease results from excessive exposure of the oesophagus to acidic contents. Acid pump inhibitors provide the most effective medical control of gastric acid throughout day and night, returning oesophageal pH to normal levels. They provide fast symptom relief and rapidly restore quality of life in all reflux patients more effectively than H2 receptor antagonists or prokinetic drugs. APIs heal oesophagitis of all grades of severity and provide safe, effective maintenance of healing with prevention of complications in longer term use.
在反流治疗药物中,酸泵抑制剂位居疗效榜首,且患者对其接受度很高,这引发了关于其作用的争论。
了解胃酸及其抑制作用在胃食管反流病发病机制和治疗中的作用。
胃食管反流病是由于食管过度暴露于酸性内容物所致。酸泵抑制剂能在昼夜全天最有效地控制胃酸,使食管pH值恢复正常水平。与H2受体拮抗剂或促动力药物相比,它们能更有效地快速缓解所有反流患者的症状,并迅速恢复其生活质量。酸泵抑制剂能治愈所有严重程度的食管炎,并在长期使用中提供安全、有效的愈合维持,预防并发症。